These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New treatment for cystic fibrosis. Kuhn RJ Am Pharm; 1994 Feb; NS34(2):16-8. PubMed ID: 8166040 [No Abstract] [Full Text] [Related]
3. A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis. Suri R; Wallis C; Bush A; Thompson S; Normand C; Flather M; Grieve R; Metcalfe C; Lees B Health Technol Assess; 2002; 6(34):iii, 1-60. PubMed ID: 12583821 [No Abstract] [Full Text] [Related]
4. Aerosolized deoxyribonuclease for cystic fibrosis. Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672 [No Abstract] [Full Text] [Related]
5. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers. Kamin W; Schwabe A; Krämer I J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502 [TBL] [Abstract][Full Text] [Related]
6. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis. Spencer DA Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860 [No Abstract] [Full Text] [Related]
7. Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis. Geller D; Thipphawong J; Otulana B; Caplan D; Ericson D; Milgram L; Okikawa J; Quan J; Bowman CM J Aerosol Med; 2003; 16(2):175-82. PubMed ID: 12823911 [TBL] [Abstract][Full Text] [Related]
8. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. Hubbard RC; McElvaney NG; Birrer P; Shak S; Robinson WW; Jolley C; Wu M; Chernick MS; Crystal RG N Engl J Med; 1992 Mar; 326(12):812-5. PubMed ID: 1538726 [No Abstract] [Full Text] [Related]
9. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis. Conway SP; Watson A Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S64-8. PubMed ID: 9155855 [No Abstract] [Full Text] [Related]
10. The timing of rhDNase in relation to airway clearance therapy-unplugged. Tannenbaum EL; Ranganathan S Pediatr Pulmonol; 2007 Dec; 42(12):1235; author reply 1236-7. PubMed ID: 17708574 [No Abstract] [Full Text] [Related]
11. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa? Coates AL J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499 [No Abstract] [Full Text] [Related]
14. Dornase alfa approved for use by cystic fibrosis patients. Am J Hosp Pharm; 1994 Apr; 51(7):869-70. PubMed ID: 8017432 [No Abstract] [Full Text] [Related]
15. Aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. Rubin BK N Engl J Med; 1992 Aug; 327(8):571. PubMed ID: 1635583 [No Abstract] [Full Text] [Related]
17. Effect of DNase on exercise capacity in cystic fibrosis. Barker M; Franke E; Böhle M; Pfannenstiel C; Heimann G Pediatr Pulmonol; 2004 Jul; 38(1):70-4. PubMed ID: 15170876 [TBL] [Abstract][Full Text] [Related]
18. Dornase alpha and exhaled NO in cystic fibrosis. Grasemann H; Lax H; Treseler JW; Colin AA Pediatr Pulmonol; 2004 Nov; 38(5):379-85. PubMed ID: 15390350 [TBL] [Abstract][Full Text] [Related]
19. Characterization of aerosols of human recombinant deoxyribonuclease I (rhDNase) generated by jet nebulizers. Cipolla D; Gonda I; Shire SJ Pharm Res; 1994 Apr; 11(4):491-8. PubMed ID: 8058603 [TBL] [Abstract][Full Text] [Related]
20. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis. Suri R; Metcalfe C; Wallis C; Bush A Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]